A selection of recent published articles and presentations
Type | Titel | Journal or event | Date | Link |
---|---|---|---|---|
Artikel | Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape. | Cambridge University Press | November 2024 | Link |
Report | Better Patient Involvement in HTA – 360° Research leads to comprehensive recommendations. | Published by HTAi | October, 2023 | Link |
Artikel | Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review. | Therapeutic Innovation & Regulatory Science. Springer | September, 2023 | Link |
Artikel | Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action. | Therapeutic Innovation & Regulatory Science. Springer | July, 2022 | Link |
Presentation. The link leads to a Podcast with a recording of the presentation. Neil starts around 48 seconds after the beginning of the podcast. | Health Technology Assessment: Global alignment of systems, stakeholders and emerging trends. | Oxford University: The presentation was part of the “Economics and Regulation in Translational Science module” which is part of the MSc in Translational Health Sciences | December, 2021 | Link |
Artikel | Deep Dive; PPI abroad: A patient advocacy perspective. – The evolving practice of patient and public involvement in Europe and The United States. | Swiss clinical trial platform – Regulatory Affairs Platform | Issue 6, 28 October 2021 | Link |
Artikel | Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19. | ZENODO | September, 2021 | Link to article. Link to press release. |
Artikel | Valuing patient engagement: reflexive learning in evidence generation practices for health technology assessment. | Social Science & Medicine | May, 2021 | Link |
Artikel | Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action. | Therapeutic Innovation & Regulatory Science (TIRS) | May, 2021 | Link |
Artikel | The Role of Patient Experience in the Value Assessment of Complex Technologies – Do HTA Bodies Need to Reconsider How Value is Assessed? | Health Policy | March, 2021 | Link |
Artikel | Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed‐methods study. | Health Expectations | February, 2021 | Link |
Artikel | Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments. | The Patient – Patient-Centered Outcomes Research | July, 2018 | Link |
Artikel | What do stakeholders expect from patient engagement: Are these expectations being met? | Health Expectations – An international Public Participation In Health Care and Health Policy | June, 2018 | Link |
Artikel | Patient Involvement in Health Technology Assessment pp 419-427: Reflections for Future Development – | Springer | May, 2017 | Link |
Artikel | Patient Centricity and Pharmaceutical Companies: Is It Feasible? | SAGE journals | March, 2017 | Link |
Artikel | Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary. | BMC | January, 2017 | Link |
Artikel | Moving Center Stage: patients claim their role in healthcare. | farmeconomia – Healtheconomics and therapeutic healthcare | January, 2016 | Link |